Conditional survival probability of distant-metastatic hepatocellular carcinoma: A population-based study

Table 1 Clinical and pathological characteristics distribution of distant metastatic hepatocellular carcinoma patients

Characteristics	n	%
Age, yr
< 55	299	19.91
55-65	656	43.68
≥ 65	547	36.42
Gender
Male	1230	81.89
Female	272	18.11
Race
White	978	65.11
Black	237	15.78
Other	287	19.11
Marital status
Single	405	26.96
Married	742	49.40
Separated	355	23.64
AFP expression
Positive	1266	84.29
Negative	236	15.71
Tumor size
≤ 5 cm	410	27.30
> 5 cm	1092	72.70
T stage
T1	337	22.44
T2	216	14.38
T3	783	52.13
T4	166	11.05
N stage
N0	1031	68.64
N1	471	31.36
Surgery
No	1420	94.54
Yes	82	5.46
Chemotherapy
No/unknown	691	46.01
Yes	811	53.99
Radiotherapy
No/unknown	1200	79.89
Yes	302	20.11
Lung metastasis
No	949	63.18
Yes	553	36.82
Bone metastasis
No	1072	71.37
Yes	430	28.63
Brain metastasis
No	1475	98.20
Yes	27	1.80
Survival status
Alive	45	3.00
Other cause death	78	5.19
Cancer specific death	1379	91.81
Total	1502	100

AFP: Alpha-fetoprotein.